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Hydroxytyrosol is one of the main phenolic components of olive oil. It is present in the fruit
and leaf of the olive (Olea europaea L.). During the past decades, it has been well docu-
mented that this phenolic compound has health benefits and a protective action has been
found in preclinical studies against several diseases. Here, we review its bioavailability in
human beings and several assays showing significant results related with cardiovascular
diseases, cancer, and acquired immunodeficiency syndrome (AIDS). Mechanisms of action
include potent anti-oxidant and anti-inflammatory effects, among others. The importance
of hydroxytyrosol in protection of low-density lipoproteins and consequently its implica-
tion in the reduction of cardiovascular disease risk has been highlighted by the European
Food Safety Authority, concluding that 5 mg of hydroxytyrosol and its derivatives should
be consumed daily to reach this effect at physiological level. We discuss the potential uses
of this compound in supplements, nutraceutic foods, or topical formulations in the dis-
ease risk reduction. Finally, we conclude that more studies are needed to sustain or reject
many other health claims not yet fully documented and to validate these newly available
hydroxytyrosol-based products, because it seems to be a good candidate to reduce the
risk of diseases mentioned.
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INTRODUCTION
HYDROXYTYROSOL AND MEDITERRANEAN DIET
Hydroxytyrosol (HOTYR) is a simple phenolic compound nat-
urally occurring in olive and olive oil, the main source of fat in
Mediterranean diet. Nowadays, it is very popular the benefits of
this diet for the maintenance of human health and wellbeing.
Anyway, the concept of Mediterranean diet may be misunder-
standing, being necessary its clarification. It was originally defined
as the dietary pattern found in some of the olive-growing regions
in the Mediterranean Basin of the 1960s. Thus, a current sim-
ple accepted definition is closely related to the diet characteristics
as source of separate types of fats. In this way, Mediterranean
diet highlights by its high proportion in plant foods where the
main source of fat is olive oil, resulting in a higher proportion
of mono unsaturated/polyunsaturated fats relative to saturated
ones (1).
The healthy benefits of the Mediterranean diet are popularly
known and are supported by numerous studies, as the well-known
“The Seven Countries Study,”which highlighted the cardiovascular
disease related mortality in Mediterranean region compared with
other countries with distinct dietary habits in the 1960s (2). This
study can be considered as pioneer and opened a high number
of researches on those foods with critical influence in the ben-
efits of the Mediterranean diet. Among them, the PREDIMED
trial (“Prevención con dieta Mediterránea”) is a large (7447 sub-
jects), parallel-group, multicenter, randomized trial for a follow-
up period of 4.8 years, whose participants were assigned to three
dietary intervention: Med-diet supplemented with virgin olive oil,
Med-diet supplemented with nuts, and low-fat diet. The results
showed an important reduction of three of every thousand per-
sons per year in the risk of major cardiovascular events among
high-risk persons.
Among the separate foods taking part of the Mediterranean
diet, olive oil is considered a crucial element, being one of the
most traded and consumed product in the world directly related
to the healthy attribution of this popular diet (1). In November
2004, the Food and Drug Administration (FDA) allowed the health
benefits of olive oil due to monounsaturated fat in reducing the
risk of coronary heart disease and recommended a daily intake of
two tablespoon (23 g) (3).
The responsible parameters of the healthy attributions of olive
oil and table olives remain poorly understood. Olive oil is mainly
composed of two groups of compounds: saponifiable lipids (98.5–
99% of the total composition) and an unsaponifiable fraction.
The main triglyceride fatty acid is the oleic acid with 55–83% of
the total fatty acid content. It also includes moderate amounts of
palmitic and linoleic acids and a low percentage of stearic and
linolenic acids. On the other hand, the unsaponifiable fraction
contains a large variety of compounds responsible for stability
and organoleptic characteristics of olive oil. This fraction consists
of primarily of hydrocarbons (squalene, carotene, lutein), terpene
compounds, sterols, phenolic compounds, and aliphatic alcohols
among others. Phenolic compounds from olive oil include four
different groups: simple phenols, i.e., tyrosol (TYR), hydroxy-
tyrosol, polyphenols (flavonoids), secoiridoids (oleuropein), and
lignans (4).
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Although the major components of olive oil are its monoun-
saturated fatty acids, mainly oleic acid, we cannot attribute the
beneficial effects of the Mediterranean diet only to these substances
because other oils, such as rape-seed or canola oil are also rich in
monounsaturated fatty acids and may produce the same benefit.
For this reason, attention has focused on the phenolic compounds,
which have showed a strong anti-oxidant capacity, of virgin olive
oil that distinguish themselves from other types of fat. The amount
of phenolic compounds present in olive oil greatly varies depend-
ing on cultivar, degree of maturation, climate, and manufacturing
process (5). Thus, extra virgin olive oil, obtained from the cold
pressing or centrifugation of the olives, is the one with higher con-
tent of total phenolic compounds. An early study showed a total
phenolic content of 232 mg/kg in virgin olive oil versus 62 mg/kg
values of refined olive oil (up to 80% less usually lost during the
refining process) (6).
In this sense, olives, olive oil source, have higher amounts of
phenolic compounds that extra virgin olive oil (oil with higher
anti-oxidant capacity). Depending on the variety of olive and
the type of processing, the phenolic content varies significantly.
As an example, total phenolic content estimated in black olives
was 16.40 g/kg dry weight, representing hydroxytyrosol 5.78 g/kg.
Tyrosol, phloretic acid, dihydrocaffeic acid, acteoside, luteolin, and
apigenin were also found. The green olives content was much
lower with 4.48 g/kg of hydroxytyrosol and only traces of other
phenolics (6, 7).
Hydroxytyrosol, 2-(3,4-dihydroxyphenyl)-ethanol (HOTYR),
is a phenolic compound present in the fruit and leaf of the olive
(Olea europaea L.), which belongs to the family Oleaceae, com-
prising species distributed throughout the temperate regions of
the world, and essentially localized in the Mediterranean basin.
Hydroxytyrosol is one of the main components of virgin olive oil,
olive mill waste water (OMWW), and olive leaf extract (OLE),
which was early identified as the strongest in vitro anti-oxidant
potential among all the olive oil polyphenols (8). As mentioned
above, the content of this compound is largely dependent on the
oil quality. Amounts range from 14 mg/kg in extra virgin olive
oil, up to <2 mg/kg (7). Other estimations increased the estima-
tion to total phenolic content of olive oil in ranges from 487.5
to 1950 mg/l, and HOTYR specifically from 20 to 84 mg/l (9).
Hydroxytyrosol in oil is found free, in acetate form or as a part
of more complex compounds like oleacein, oleuropein, and ver-
bascoside (10) (Figure 1). Oleuropein is responsible for the bitter
taste of olives and decreases as the fruit ripens turning into ungly-
cosylated form, oleuropein aglycone by enzymatic hydrolysis, and
finally converted into hydroxytyrosol, being this one an indicator
of maturation of the olives (11, 12) (Figure 2).
Hydroxytyrosol, with a molecular weight of 154.16 is a white
powder with melting point around 55°C and is fairly soluble in
water and polar organic solvents such as low-molecular weight
alcohols. Like other polyphenols, it is easily oxidized in aqueous
solutions unless adequate precautions, acid pH, and absence of
oxidants, are taken. As it was noted at the beginning, HOTYR is
considered by far the main simple phenolic compound of table
olives (13) although the concentration depends on olive variety
(11), maturation, and the processing method (7). Besides, the
FIGURE 1 | Hydroxytyrosol and derivatives in olive and olive oil. Adapted from Boskou (10).
FIGURE 2 | (A) Oleuropein-glycoside ripening olives and olive oil. (B) Oleuropein-aglycone. (C) Hydroxytryosol. Adapted from Charoenprasert et al. (12).
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concentration of phenolic compounds is different when compar-
ing table olives and raw fruit due to manufacturing process. For
example, in the preparation process of the Californian-type black
olives, levels of HOTYR and caffeic acid decreases in the darkening
process (14). Therefore, the beneficial properties for human health
found in olive oil could also be supposed and extended in table
olives. Moreover, HOTYR was identified in olive pits as shown
by a 2001 patent explaining the synthesis of this compound by a
process of quick autohydrolysis (15). Another natural source of
HOTYR is red wine (16), and although the concentrations found
are lower than those found in olive oil, unsettling bioavailability
studies reveal the emergence of higher quantities of HOTYR con-
centrations than those administered, in urinary recoveries after
administration of red wine. An interaction between ethanol and
dopamine leading to the formation of hydroxytyrosol was sug-
gested as a possible explanation to this fact (17). Therefore, all
these data reveal the relevance of HOTYR consumption by olive
products, which are regularly consumed in the Mediterranean diet
and ensure a daily contribution to the human health.
ABSORPTION AND BIOAVAILABILITY
The term bioavailability is commonly used to indicate the pro-
portion of a substance that reaches the systemic circulation after
oral administration considering both its absorption and its local
metabolic transformation.
There are several assays dealing with the absorption of olive oil
phenolic compounds both in animals (18, 19) and human beings.
Visioli et al. (9) found a high correlation for TYR and HOTYR in
human urine respect the ingested of different phenolic amounts
in olive oil. The urine hydrolyzed using glucuronidase enzyme
revealed the high grade of conjugation of HOTYR and an increas-
ing conjugation degree in higher phenolic content oils was found.
Miró-Casas (20) also demonstrated the absorption of hydroxyty-
rosol in a study with human beings after ingestion of olive oil. The
recovery reached for hydroxytyrosol was 121.1% when was admin-
istered as a maintenance dose of 25 ml/day for 1 week. These data
have been also found in other studies (17, 21, 22) and different
explanations have been offered, like the hydrolysis of precursors
also present in olive oil, long-term accumulation and dopamine
metabolism. Studies using different techniques to determine the
amount of absorbed hydroxytyrosol as isotopic labeled (19) esti-
mated absorption around 99% of totally intake in oil and 75% in
aqueous solution, being<3% in fecal content. Around 55–66% of
absorption was found too with aqueous supplements in ileostomy
patients (23).
Related to phenolic compounds absorption, the influence of
the delivery vehicle seems to be crucial. In human beings, HOTYR
absorption was higher when subjects ingested virgin olive oil than
in refined oil (phenol-free) enriched with phenolic compounds, or
when HOTYR was incorporated into a yogurt as functional food,
with urinary recoveries of 44, 23, and 5.8%, respectively (21). In
this direction, clinical trials have demonstrated that the amount
of hydroxytyrosol in free form was undetectable being 98% in
conjugated form, mainly glucuronides, in plasma, and urine (9,
24). These data provided an idea of the bioavailability of hydroxy-
tyrosol, to highlight that olive oil phenolics are well absorbed at the
intestinal level, suggesting that the intestinal/hepatic metabolism
of the ingested phenolics is extensive. Almost all phenolic con-
tent are present in plasma and urine in conjugated forms mainly
glucurono-conjugates. Taking into account that the amount of
free HOTYR in plasma and urine is almost undetectable, some
authors suggest to attribute the biological activity to metabo-
lites of HOTYR. In this direction, there are controversial studies
about the biological activities of HOTYR and its conjugated forms.
In a study in rats, 3-O-glucuronide conjugated HOTYR showed
higher activity as a radical scavenger than its corresponding free
form (25). More recently, Khymenets et al. (26) showed that
two glucuronides, 3-O-Gluc-HOTYR and 4-O-Gluc-HOTYR, did
not show radical scavenging activity and capacity to protect low-
density lipoproteins (LDL) against oxidation compare to HOTYR.
In both articles, DPPH assay is used but under different concen-
trations and solvent. Thus, there is a need for standardization for
free-radical assays in order to provide reliable data (27).
CARDIOVASCULAR DISEASES
Numerous studies have demonstrated the importance of naturally
occurring dietary polyphenols in promoting cardiovascular health
(28). Within the Mediterranean diet much research has focused
on active phenolic compounds present in virgin olive oils to aid
in explaining reduced mortality and morbidity observed (29).
Among them, two isolated compounds, oleuropein and hydrox-
ytyrosol, have received special attention (30). These compounds
show several anti-inflammatory and anti-atherogenic activities,
such as the inhibition of LDL oxidation, platelet aggregation, and
other factors involved in the development of atherosclerosis.
EFFECTS ON ENDOTHELIAL DYSFUNCTION
Reactive oxygen species (ROS) are critically involved in the
endothelial dysfunction that contributes to atherosclerosis devel-
opment. Oxidative stress-induced endothelial dysfunction prob-
ably represents one of the first stages in the development of
atherosclerotic lesions (31, 32). Accordingly, the atherosclerotic
vessel wall contains increased levels of ROS, which affect several
redox–sensitive pathways in vascular cells, resulting in a markedly
altered cellular composition of the tissue. Migration and prolif-
eration of vascular smooth muscle cells in the area is induced, as
well as expression of adhesion molecules and chemotactic factors
by the endothelium (33). Consequently, increased arterial adhe-
siveness at predisposed sites provides an excellent environment for
local infiltration of circulating immune cells, resulting in chronic
inflammation (34). Thus, direct reduction of levels of ROS and/or
stimulation of anti-oxidant defenses at these levels could avoid
atherosclerosis development.
It has been observed in animal models that levels of several
anti-oxidant enzymes decline during atherogenesis (35). Incuba-
tion of porcine pulmonary artery endothelial cells (VECs) with
HOTYR in the presence of H2O2 prevents the increase in intracel-
lular ROS levels (36). HOTYR increases catalase mRNA, protein,
and activity of both cytosolic and nuclear protein levels of fork-
head transcription factor 3a (FOXO3a), which directly increases
the expression of anti-oxidant enzymes, as well as the phospho-
rylation of AMP-activated protein kinase (AMPK) that translo-
cates FOXO3a to the nucleus. Thus, these findings demonstrate
that HOTYR positively regulates the anti-oxidant defense system
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in VECs and provides a molecular basis for the prevention of
cardiovascular diseases by HOTYR.
Another study analyzed the effects of HOTYR on anti-oxidant
status and the progression of aortic lesions in hyperlipemic rabbits.
After 1-month of controlled diet 50 and 42% decrease in total cho-
lesterol and triacylglycerols, respectively, and a 2.3-fold increase
in HDL-cholesterol were observed. The HOTYR-supplemented
groups also improved their anti-oxidant status and reduced the
size of atherosclerotic lesions measured as intimal layer areas of
the aortic arch when compared with control animals (37).
In 2003, Carluccio et al. (38) found that at nutritionally rel-
evant concentrations, oleuropein and hydroxytyrosol, among all
the tested molecules present in olive oil and red wine, reduced
monocytoid cell adhesion to stimulated endothelium, as well as
vascular cell adhesion molecule-1 (VCAM-1) mRNA and protein
in human umbilical vein endothelial cells incubated for 30 min
with the phytochemicals, followed by co-incubation with bacte-
rial lipopolysaccharide or cytokines to trigger adhesion molecule
expression. The relevance of nuclear factor-NF-κB and activator
protein-1 confirmed by electrophoretic mobility shift assays, and
possibly GATA binding sites in mediating VCAM-1 transcriptional
inhibition, was observed in this case.
PROTECTION OF LDL PARTICLES FROM OXIDATIVE DAMAGE
In 1995, an experimental study conducted by Visioli showed
in vitro the inhibitory effect of hydroxytyrosol and two deriv-
ative compounds on LDL oxidation (39). Different indices of
lipid oxidation such as vitamin E content, formation of thiobarbi-
turic acid-reacting substances (TBARS), lipid peroxidases, levels of
polyunsaturated fatty acids, protein modification, and conjugated
diene formation were used. Copper sulfate and horseradish per-
oxidase/hydrogen peroxidase were used as LDL oxidation systems.
Hydroxytyrosol and two derivatives at 10−5 M almost completely
inhibited conjugated diene formation induced by 5µM copper
sulfate as oxidant in LDL incubation samples. The mechanism of
action proposed for this phenolic compounds were the scavenging
free radicals and/or acting as chelating agents and thus depress-
ing the superoxide-driven reactions and breaking the propagation
chain of peroxides (40).
More than 15 years after the first study, the European Food
Safety Authority (EFSA) published a scientific opinion related to
polyphenols in olive, and The EFSA Panel on Dietetic Products,
Nutrition, and Allergies regarded about the relationship between
the consumption of olive oil polyphenols and protection of LDL
particles from oxidative damage (41). The panel considered that
5 mg of hydroxytyrosol and its derivatives in olive oil should be
consumed daily to reach this effect at physiological level. This
amount of hydroxytyrosol must be contained in a maximum of
20 g of oil to be considered within a balanced diet. Considering
that the oxidation of LDL plays an important role in the devel-
opment of atherosclerosis, this communication brings robust data
on the implication of phenolic compounds in coronary heart dis-
ease. This scientific opinion was supported by consistent studies
showing the relationship between phenolic compounds in olive oil
and LDL oxidation. To provide its opinion EFSA took into account
several studies demonstrating the involvement of phenolic com-
pounds as protectors of LDL oxidation. Other studies have been
reviewed with results in the same direction as those previously
recognized by EFSA. Data are shown in Table 1.
In general, olive oil polyphenols may have anti-oxidant protec-
tive properties not only by the free-radical scavenging but also for
the modulation of gene expression such the CD40 ligation and
its downstream products in human beings. It has been observed
that intake of high content of phenolic compounds from olive oil
(366 mg/kg) reduced the expression of CD40 ligand gene and its
downstream products, and was associated with a decrease in oxi-
dized LDL in plasma and an increase in urinary polyphenols (40).
INHIBITION OF PLATELET AGGREGATION
Another process involved in the development of atherosclerotic
lessions is platelet aggregation, which is the previous step in throm-
bus formation (49). HOTYR can be considered anti-thrombotic,
since it significantly reduces platelet aggregation. While Dell’Agli
et al. (50) found positive results for HOTYR in the reduction of
human platelet aggregability but not through the inhibition of
cAMP- and cGMP-phosphodiesterases as the targets of the bio-
logical effect as the other olive oil polyphenols tested in their
study, early works of Petroni et al. (51) and more recently Léger
et al. (52) in human blood samples from healthy volunteers and
patients with uncomplicated diabetes type 1, respectively, also
suggest anti-platelet aggregation activity. In these studies, a reduc-
tion in thromboxane B2 levels, a chemically stable and inactive
form of thromboxane A2, which acts as platelet aggregating and
vasoconstrictor, was measured. Another comparative study (53)
with mildly dyslipidemic patients reached similar results, finding
a decrease in the production of thromboxane B2 and an increase
in plasma anti-oxidant capacity after consumption of HOTYR
contained in extra virgin olive oil (166 mg/l; estimated ingestion
6.64 mg/day) compared with the absence of results in the case
of a low intake from a refined oil (2 mg/l; estimated ingestion
0.02 mg/day).
Gonzalez-Correa et al. (54) also found HOTYR and HOTYR-
acetate as inhibitor of platelet aggregation in rats after oral admin-
istration for 7 days, with similar effectiveness of acetyl salicylic
acid. In this case,mechanisms involved in this effect were a decrease
in thromboxane synthesis and an increase in vascular nitric oxide
(NO) production.
ANTI-INFLAMMATORY EFFECTS
In vitro and in vivo studies (55) taken as a model of inflam-
matory response in rats plantar edema induced by carrageenan
shows hydroxytyrosol as inhibitor of cyclooxygenases 1 and
2, which convert arachidonic acid to prostaglandins, resulting
in pain and inflammation, at the same level as widely used
drugs such as ibuprofen and celecoxib. In studies with human
monocytic cells, THP-1 (56) treated with lipopolysaccharides to
induce inflammatory response HOTYR showed the inhibition of
pro-inflammatory cytokines (TNF-α) and reduced the expression
of cyclooxygenase-2 and inducible nitric oxide synthase (iNOS)
more than 60%.
Beneficial effects were also found (57) in patients with stabilized
coronary disease. The intake of virgin olive oil, rich in polyphenols,
was shown to be more effective than refined olive oil in pro-
ducing a decrease in interleukin-6 (IL-6) and C-reactive protein
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Table 1 | Protection of LDL from oxidation
Study type Anti-oxidant capacity measurement Conclusion Reference
Incubation of hydroxytyrosol and two
conjugated of HOTYR with isolated LDL
Concentration Vit.E in LDL in presence of copper
sulfate with different concentration HOTYR
HOTYR and conjugated, copper
sulfate-induced LDL oxidation
(39)
TBARS level
Levels of lipid peroxide
Conjugated dienes formation
Refined olive oil, common olive oil and
virgin olive oil were added to isolated
low-density lipoprotein
Conjugated dienes formation was monitored
after copper-mediated LDL oxidation
Oils with higher content of phenolic
compounds showed the greatest protection
of LDL oxidation
(42)
Dietary study in human beings
consuming virgin olive oil
Variables used to study the resistance of LDL:
lag time, maximum amount of dienes and
maximal oxidation rate
Decrease in LDL cholesterol and LDL
oxidation during one week period consuming
25 ml of olive oil. Significantly levels of MUFA
and anti-oxidants in LDL
(43)
Double-blind, crossover, randomized,
controlled clinical trial to investigate the
effects of olive oil with differences in their
phenolic content on LDL oxidation
Ox-LDL was determined in plasma by a
sandwich ELISA procedure. The LDL resistance
to oxidation was determined by formation of
conjugated dienes after copper oxidation of
isolated LDL
Decrease in vivo LDL oxidation and
resistance to ex vivo (isolated) LDL oxidation
(44)
Double-blind, randomized, crossover
experimental trial in human beings
consuming olive oil
Ox-LDL measured by the ELISA method Significant decrease in plasma oxidized LDL
in dose-dependent manner in relation with
the phenolic content of the olive oil ingested
(45)
Multicenter controlled human intervention
consuming olive oil with differences in
their phenolic content (EUROLIVE)
Ox-LDL measured by a sandwich ELISA
procedure using murine monoclonal antibody
mAb-4E6
Significant decrease in plasma oxidized LDL
in dose-dependent manner in relation with
the phenolic content of the olive oil ingested
(46)
Dietary study in human beings consuming
olive oil with differences in their phenolic
content
Ox-LDL measured by enzyme immunoassay
using murine monoclonal antibody mAb-4E6
Dose-dependent response between the
intake of polyphenols and the decrease in
LDL peroxidation
(47)
Subsample of EUROLIVE study. Human
intervention consuming olive oil with
differences in their phenolic content
Ox-LDL in plasma measured by a sandwich
ELISA with murine monoclonal antibody
mAb-4E6. Anti-oxidant capacity of biological
metabolites of phenolic compounds
(hydroxytyrosol monosulphate and homovanillic
acid sulfate)
Inverse relationship between these
metabolites and the degree of LDL oxidation
(48)
HOTYR, hydroxytyrosol; LDL, low-density lipoproteins; Vit. E, vitamin E; CuSO4, copper sulfate;TBARS, thiobarbituric acid-reacting substances; ELISA, enzyme-linked
immunosorbent assay; MUFA, monounsaturated fatty acids; Ox-LDL, oxidized low-density lipoproteins.
(CRP) levels, recognized inflammatory markers in cardiovascular
disease (58).
A DSM study from the human nutrition and health depart-
ment (59) describes hydroxytyrosol as the most powerful anti-
inflammatory compound among polyphenols of olive oil, showing
effective inhibition in the production of NO and PGE2, decreas-
ing secretion of cytokines (IL-1α, IL-1β, IL-6, IL-12, TNF-α)
and chemokines (CXCL10/IP-10, CCL2/MPC-1) and reducing
gene expression of iNOS, IL-1α, CXCL10/IP-10, MIP-1β, matrix
metaloproteinase-9, and prostaglandin E2 synthase (PGES).
Very recently, Killen et al. (60) have reviewed the HOTYR
ability to modulate the transcription factor NF-κB whose acti-
vation triggers the expression of over 150 genes, including those
encoding cytokines, such as tumor necrosis factor alpha (TNF-α),
interleukin (IL)-1, IL-6, and IL-17, chemokines and adhesion
molecules, implicated in both physiological and pathophysiologi-
cal inflammatory responses.
Data from these studies provide a molecular basis for elucidat-
ing the effects of HT on inflammatory processes. Concentrations
reached after dietary intake of olive oil results in appropriated val-
ues of HOTYR for inhibiting the NO and PGE2 production and
significant modulation of gene expression. Therefore, exposure to
lower levels of HOTYR by regular dietary intake might repeatedly
modulate physiological parameters that provide a systemic health
benefit.
HYDROXYTYROSOL AND CANCER
Cancer is among the most deadly diseases today. For this rea-
son, scientists have sought alternatives to prevent these diseases
or to improve the quality of life of patients. It has been estimated
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that more than two thirds of human cancers could be prevented
through appropriate lifestyle, which includes a proper nutrition
(61). Over the past 20 years, many studies in human beings have
indicated an inverse correlation between regular fruit and veg-
etable consumption and development of various types of cancer
(62, 63). Currently, one approach with enormous potential is can-
cer chemoprevention (64). Chemoprevention as first defined by
Sporn in 1976, uses natural, synthetic, or biologic chemicals agents
to reverse, suppress, or prevent carcinogenic progression to inva-
sive cancer (65). The chemoprevention by dietary phytochemicals
is gaining increasing attention because of their ability to modulate
a plethora of signal transduction pathways in different types of
cancer (66).
Polyphenols are found within the group of substances with
chemo-preventive properties as they affect several mechanisms,
including removal of cancer agents, modulation of cancer cell
signaling and cell cycle progression, promotion of apoptosis,
and modulation of enzymatic activities. High concentrations of
polyphenols from olive and olive products, throughout history,
have been heavily exploited for risk reduction of several chronic
diseases. In particular, the consumption of extra virgin olive oil is
associated with a risk reduction of certain cancers supported by
several epidemiological studies in human beings (67). These health
benefits can be attributed more toward phenolic compounds than
to its fatty acid profile (68, 69). Highlighting, HOTYR is one of the
main phenolic components that has shown potent anti-oxidant,
anti-atherogenic, anti-thrombotic, and anti-inflammatory activity
(70). In other cases, derivatives like oleuropein and other related
polyphenols instead of HOTYR were found to be responsible for
cytotoxic activity (71, 72).
Regarding the cancer chemo-preventive activities, it has been
shown that HOTYR is able to inhibit both initiation and promo-
tion/progression phases of carcinogenesis by preventing the DNA
damage induced by different genotoxic molecules and by inhibit-
ing proliferation and inducing apoptosis in different tumors cell
lines, respectively (73, 74). Cell culture studies constitute a valu-
able tool for identifying the molecular targets modulated by dietary
phenolic compounds in cancer cells and for elucidating the mole-
cular pathways involved in the overall disease process (75). Like a
considerable number of anti-oxidants, hydroxytyrosol, and oleu-
ropein are reported to produce extracellular hydrogen peroxide
under standard culture conditions (76, 77). Factors responsible
for this pro-oxidant behavior were identified (78) and several
strategies have been developed to correct artifacts (79). Anyway,
pro-apoptotic effects were observed in HL60 cells incubated with
HOTYR even in conditions not supporting H2O2 accumulation
(between 23.8 and 38.0% depending on the media) suggesting
that other mechanisms, in addition to the H2O2-releasing activ-
ity, could be involved in the pro-apoptotic activity (80). On the
other hand, hydrogen peroxide is also known to play a role in cel-
lular signaling (81). Thus, polyphenols might be beneficial due to
its contribution to redox homeostasis. A higher decrease in normal
levels of ROS could be detrimental to health,which could be also an
explanation to negative results obtained in several studies (64, 65).
The role of HOTYR as a chemo-preventive anti-carcinogenic
compound has received attention in human carcinoma cells in
many in vitro studies showing significant effects in several cancer
cell lines as main responsible compound, either alone or in a syn-
ergistic manner (82), arresting the cell cycle at any of its phases,
producing differentiation, apoptosis, or preventing DNA from
oxidative stress (Table 2).
Besides, some structural modifications trying to incorporate
the well-known benefits of organo-sulfur compounds have been
also done. Recently, it was found that the introduction of sulfur
containing functional groups on HOTYR molecule leads to an
enhancement of chemo-preventive activity in HL60 and HL60R
cell lines, suggesting that they could be able to reverse the resistance
toward the most common anti-cancer drugs (100).
Briefly summarizing, the general approach to health ben-
efits of polyphenols comes from their anti-oxidant and anti-
inflammatory effects (101). These effects can be observed in in vivo
studies with HOTYR. As an example, it showed protection against
oxidative stress induced by Cyclosporine-A by scavenging most
radical species, measured by the increase of GSH/GSSG ratio
and the decrease of lipid peroxidation levels in tubular cells in
rats (102). Another study that looked at anti-cancer effects of
HOTYR is found in the inhibition of growth and cell prolifera-
tion in Sprague Dawley rats with experimental mammary tumors
(103). In addition to these findings, another in vivo study with
HOTYR (250 and 500 mg/kg/day) markedly inhibited the growth
of cholangio-carcinoma xenografts in mice, through G2/M phase
cell cycle arrest and apoptosis (99).
Epidemiological studies have suggested that HOTYR may have
protective effects against several types of cancer (104). Likewise,
antitumor effects of olive derivatives have been reported for differ-
ent organs of the body such as the pancreas, oral cavity, esophagus,
colon–rectum, prostate, and lung (105). In the colon cancer case it
is mentioned that if the HOTYR would reach the colon in a distrib-
ution volume of around 250 ml, it would result in a concentration
of approximately 72µmol/l, a value that induced a 50% inhibi-
tion of cell proliferation. Accordingly may exert chemo-preventive
activity on colon cancer inhibiting cell proliferation (106).
As shown, most studies to date have been investigated in cell
lines and a relative few number of studies are in animals or human
beings. Therefore, for a better understanding of the potential and
mechanisms of HOTYR specific antitumor activity, both in vitro
and in vivo, and with animals and human beings studies are
necessary.
EFFECTS OF HOTYR ON HUMAN IMMUNODEFIENCY VIRUS
Acquired immunodeficiency syndrome (AIDS) is a disease of
the human immune system caused by infection with human
immunodeficiency virus (HIV).
Despite the existence of drugs and combinations against the
HIV virus to reduce the morbidity and mortality of patients, they
do not cure the infection. Moreover, anti-HIV therapies must be
maintained long-term with important chronic toxicity and drug
resistance problems. Therefore, further research is needed to reach
the complete healing. Meanwhile, the prevention of transmission
and virus proliferation, as well as palliatives against HIV-derived
diseases plays a crucial role. At the final of the last century up to
half of patients infected with the HIV virus were estimated to use
alternative therapies in addition to standard therapy (107). As an
example, some efforts were made to diminish side effects of this
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Table 2 | Chemo-preventive properties of hydroxytyrosol in studies of cancer cell lines
Cancer Cell line Cellular effects Capacity of HT in cancer Reference
Leukemia HL60 Cell cycle arrest (G0/G1 or G2/M) Antiproliferative (74)
Pro-apoptotic (83, 84)
Inhibition on DNA synthesis Antiproliferative and pro-apoptotic (85)
Induction of differentiation
Colon cancer HT29 G2/M phase cell cycle arrest Antiproliferative (74)
Growth arrest. Stress of the endoplasmic reticulum.
Inhibits NF-κB
Antiproliferative and pro-apoptotic (86)
G2/M phase cycle arrest
Caco-2 Inhibition of p38/CREB phosphorylation and reduction
COX-2 expression
Antiproliferative (87)
Inhibition of ERK1/2 phophorilation and cyclin D1 levels Antiproliferative (88)
Up-regulating p21 and CCNG2 and down-regulating
CCNB1 protein expression
Pro-apoptotic (89)
SW620 S phase cell cycle arrest. Inhibition of FAS expression Antiproliferative and pro-apoptotic (90)
HT115 Inhibits invasion of cancer colon cells Anti-invasive (91)
Breast cancer MCF-7 G0/G1 cell cycle arrest Antiproleferative and pro-apoptotic (92, 93)
Inhibition of estradiol induced ERK1/2 phosphorylation Antiproliferative (94)
SKBR3 Delay cell cycle in G2/M phase Antiproliferative and pro-apoptotic (95)
T-47D
MB231 Inhibits CCL5 accumulation and consequently the
increase in the ERK1/2-cyclin D1 pro-proliferative pathway
Antiproliferative and pro-apoptotic (96)
Hepatocellular carcinoma HCC Induction of G2/M cell cycle arrest and apoptosis Antiproliferative and pro-apoptotic (97)
Suppression of the AKT and NF-κB pathways activation
HepG2 Protection of oxidative stress produced by tBuOOH (98)
Cholangio-carcinoma TFK-1 G2/M phase cell cycle arrest Antiproliferative and pro-apoptotic (99)
KMBC Inhibition of phospho-ERK
GBS-SD
COX-2, cyclooxygenase-2; DNA, deoxyribonucleic acid; ERK1/2, extracellular-signal-regulated kinases 1 and 2; cyclin D1, cyclin-dependent kinase 1; CCNG2 and
CCNB1, genes that encode cyclin G2 (inhibitor or cell cycle progression) and cyclin B1 (regulatory protein evolved in mitosis); FAS, fatty acid synthase; NF-κB, nuclear
factor kappa-light-chain-enhancer of activated B cells; p21, cyclin-dependent kinase inhibitor 1A (also known as p21WAF1/Cip1); CCL5, chemotactic citokine C–C motif
ligand 5; AKT, protein kinase B (involved in metabolism, apoptosis, and proliferation processes); tBuOOH, tert-butyl hydroperoxide; ERK, extracellular signal-regulated
kinases.
disease such as oral thrush or diarrhea, with alternative therapies
such as lemon juice or lemon grass infusion (108) or traditional
Chinese herbal medicines (109).
In 2003, Lee-Huang et al. (110), in an in vitro study observed
that OLE inhibits acute infection and cell-to-cell transmission
between uninfected MT2 cells co-cultured with human immun-
odeficiency virus type 1 (HIV-1) infected H9 T lymphocytes in
a dose-dependent manner, with an EC50 of around 0.2µg/ml.
Moreover, OLE also inhibits HIV-1 replication, as assayed by p24
(capside virus protein) expression an EC50 of 0.23µg/ml. It was
found that oleuropein, the derivative of HOTYR, was the OLE
compound responsible of the highest anti-HIV activity.
In this sense, newly studies using molecular docking simu-
lation showed that oleuropein and HOTYR were the effective
components of OLE, which inhibit the HIV-1 fusion core for-
mation and it was confirmed by EC50s of 66–58 nM. They are
active against multiple stages of HIV-1 life cycle, inhibiting cell-
to-cell transmission and viral core antigen p24 production. In one
hand, in HIV-1 fusion, the transmembrane subunit gp41 from
HIV-1 envelope glycoprotein mediates fusion of the virus with
the target cells and both oleuropein and HOTYR are also able
to inhibit the fusion promoting refolding of gp41. This study
compared oleuropein and HOTYR with Furzeon (T-20 or Enfu-
virtide), the only HIV fusion inhibitor approved by the FDA, in
terms of fabrication given the difficulty of manufacturing of this
drug due to this high-molecular weight. Instead of this oleuropein
and HOTYR are easily obtainable from olive oil or OLE and also
can be synthesized in the laboratory (111). On the other hand,
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the same authors examined the molecular integration of OLE and
HOTYR with HIV-1 integrase, which is an essential enzyme for
retroviral replication and is involved in the integration of HIV
DNA into host chromosomal DNA. They observed that OLE and
HOTYR exhibited dose-dependent inhibition on all three activ-
ities of this enzyme including 3′-processing, strand transfer, and
disintegration (112).
The use of natural small molecules, combining anti-
inflammatory and anti-viral effects has recently received special
attention to prevent HIV infection and even to palliate HIV-
derived diseases. In the case of HOTYR, this has been reflected
in two patents in the last decade, either for reducing inflamma-
tory derived diseases (113) or for direct prevention of the HIV
infection (114).
CURRENT AND POTENTIAL USES IN HEALTH CARE
We have reviewed the properties of hydroxytyrosol, focusing on
the protection against cardiovascular diseases and progresses on
diseases like cancer or AIDS. Other benefits can be attributed to
this and other phenolic compounds in olive such as maintenance
of normal blood HDL-cholesterol concentrations, maintenance
of normal blood pressure, anti-inflammatory properties, con-
tribution to the upper respiratory tract health, maintenance a
normal function of gastrointestinal tract, and contribution to body
defenses against external agents, although only a cause-effect rela-
tionship between the consumption of olive oil polyphenols and
protection of LDL particles from oxidative damage has been firmly
recognized (41).
More conclusive studies are needed to link all these poten-
tial benefits with phenolic compounds such as HOTYR and OLE
and thus to involve new lines of research into drugs that pre-
vent and treat these diseases. On the other hand, according to
other reviews (41, 115), the average intake of olive oil ranges
30–50 g/day in the Mediterranean countries. This would be an
estimated intake around 9 mg of phenolic compounds per day.
In a recent study, De la Torre et al. (116) estimate the intake of
tyrosol and HOTYR from virgin olive oil of a population from
southern Spain in the range of 88.5–237.4µg/day. Another esti-
mation based on a study of Greek origin with six types of olive oil,
which analyzes the concentration of phenolic compounds, tyrosol,
and HOTYR, concluded that the daily intake of hydroxytyrosol
in the Mediterranean area would be 2 mg (considering the max-
imum 50 mg/day) (115). This amount would be insufficient to
reach the recommended amount of 5 mg to develop the benefit of
protection of LDL particles from oxidative damage. It would be
possible to consider supplements or nutraceutics that may ensure
that doses. In fact, different products are already in the market con-
taining hydroxytyrosol as Mediteanox®, Hydrox®, and Hytolive®.
Different types of presentations appearing on the market, such as
capsules, elixir, creams, and even an extra virgin olive oil with a
very high content of hydroxytyrosol (over 500 mg/kg). Hydrox®
and Hytolive® have been granted the generally recognized as safe
(GRAS). Even synthetic pure hydroxytyrosol, commercialized by
SEPROX BIOTECH,has reached this status and it has been recently
proposed in EU for Novel Food. Some of these products have
been already tested successfully showing some of the previously
described health benefits (117–119).
The lack of adverse effects at high levels has been pointed out
several times at acute dose (120) or after prolonged consumption
(121). Pure hydroxytyrosol has been also evaluated in a recent
toxicological study in rats, and a no observed adverse effects level
(NOAEL) of 500 mg/kg/day of hydroxytyrosol has been proposed.
The toxicological evaluation included clinical signs, grip strength,
locomotor activity, food consumption, body weight, hematology,
clinical biochemistry, pathology, organ weights, and microscopic
findings and the authors did not find toxicological relevance
effects (122).
Besides, the European Commission has funded a research that
will try to test the efficacy of hydroxytyrosol in the prevention
of HIV infection. In a few years, this compound could become a
microbicide gel to prevent HIV transmission during sex (123).
We may conclude that HOTYR is an extraordinary molecule
with recognized beneficial properties. Some of them are well-
contrasted and recognized by safety agencies. However, further
investigations are necessary for better understanding of its mecha-
nism of action on other diseases such as cancers or AIDS. This will
clarify important characteristics of this substance, which helps in
the prevention for these diseases.
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